We are live on !
Find out more
BE
Bonness Enterprises Portfolio holdings
AUM
$307M
Turnover
5.13%
1-Year Est. Return
22.88%
This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+22.88%
3 Year Est. Return
+98.56%
5 Year Est. Return
+145.32%
10 Year Est. Return
+437.4%
AUM
$307M
AUM Growth
-$2.61M
(-0.84%)
Cap. Flow
+$4.39M
Cap. Flow % of AUM
Cap. Flow %
1.43%
Top 10 Holdings %
Top 10 Hldgs %
71.26%
Holding
39
New
2
Increased
–
Reduced
1
Closed
–
Avg Time Held
11.8
years
Top 10 Avg Time Held
6.5
years
Top 20 Avg Time Held
8.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$4.21M |
| 2 |
Chevron
CVX
|
+$217K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$31.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.75% |
| 2 | Technology | 28.67% |
| 3 | Healthcare | 23.31% |
| 4 | Industrials | 3.32% |
| 5 | Consumer Staples | 2.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Progressive
PGR
$134B
| $106M | 34.48% |
511,457
| – | – |
2013 Q2
53 quarters
|
|
2
Microsoft
MSFT
$3.88T
| $19.5M | 6.34% |
37,990
| – | – |
2013 Q2
53 quarters
|
|
|
3
Stryker
SYK
$112B
| $16.8M | 5.47% |
61,039
-100
| -0.2% | -$31.5K |
2013 Q2
53 quarters
|
|
4
Apple
AAPL
$5.03T
| $16.3M | 5.31% |
49,070
| – | – |
2013 Q2
53 quarters
|
|
5
Applied Materials
AMAT
$310B
| $11.1M | 3.62% |
21,776
| – | – |
2013 Q2
53 quarters
|
|
6
Johnson & Johnson
JNJ
$658B
| $10.2M | 3.32% |
38,538
| – | – |
2013 Q2
53 quarters
|
|
7
Merck
MRK
$369B
| $10.1M | 3.28% |
69,500
| – | – |
2013 Q2
53 quarters
|
|
8
Intel
INTC
$350B
| $9.8M | 3.2% |
81,850
| – | – |
2013 Q2
53 quarters
|
|
9
AbbVie
ABBV
$521B
| $9.7M | 3.14% |
36,900
| – | – |
2013 Q2
53 quarters
|
|
10
Cisco
CSCO
$412B
| $9.5M | 3.09% |
88,400
| – | – |
2013 Q2
53 quarters
|
|
11
Corning
GLW
$106B
| $8.12M | 2.64% |
52,800
| – | – |
2014 Q2
49 quarters
|
|
12
Emerson Electric
EMR
$92B
| $6.67M | 2.17% |
43,000
| – | – |
2013 Q2
53 quarters
|
|
13
IBM
IBM
$244B
| $6.5M | 2.11% |
29,564
| – | – |
2013 Q2
53 quarters
|
|
14
Thermo Fisher Scientific
TMO
$258B
| $5.99M | 1.95% |
8,875
| – | – |
2013 Q2
53 quarters
|
|
15
Nucor
NUE
$62.1B
| $5.48M | 1.78% |
23,435
| – | – |
2013 Q2
53 quarters
|
|
16
Pfizer
PFE
$174B
| $5.09M | 1.65% |
178,308
| – | – |
2013 Q2
53 quarters
|
|
17
Marsh
MRSH
$95.4B
| $4.32M | 1.4% |
25,300
| – | – |
2013 Q2
53 quarters
|
|
|
18
Unilever
UL
$141B
| $4.07M | 1.32% |
+66,985
| New | +$4.21M |
2026 Q3
0 quarters
|
|
19
Hewlett Packard
HPE
$73.1B
| $3.65M | 1.19% |
57,100
| – | – |
2015 Q4
43 quarters
|
|
20
Bristol-Myers Squibb
BMY
$128B
| $3.39M | 1.1% |
54,300
| – | – |
2013 Q2
53 quarters
|
|
21
Abbott
ABT
$184B
| $3.23M | 1.05% |
32,700
| – | – |
2013 Q2
53 quarters
|
|
22
Agilent Technologies
A
$49.3B
| $3.08M | 1% |
17,900
| – | – |
2013 Q2
53 quarters
|
|
23
ING
ING
$89.4B
| $2.91M | 0.95% |
82,000
| – | – |
2013 Q2
53 quarters
|
|
24
Coca-Cola
KO
$405B
| $2.42M | 0.79% |
28,100
| – | – |
2013 Q2
53 quarters
|
|
25
Procter & Gamble
PG
$374B
| $2.38M | 0.77% |
16,400
| – | – |
2013 Q2
53 quarters
|
|
Similar funds
ECH
Bonness Enterprises's Q3 2026 Portfolio in Review
As of Q3 2026, Bonness Enterprises held 39 positions worth $307M, down 0.84% from $310M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Bonness Enterprises's Q3 2026 filing shows 2 new and 1 reduced positions. Its largest new stake was Unilever: 66,985 shares worth $4.07M. The largest sale was Stryker, an estimated $31.5K.
By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 39% a quarter earlier, followed by Technology and Healthcare.
- Bonness Enterprises's largest Q3 2026 buy was Unilever: 66,985 shares worth $4.07M.
- Bonness Enterprises's biggest Q3 2026 reduction was Stryker, cutting an estimated $31.5K.
- Bonness Enterprises's ten largest holdings make up 71% of its $307M portfolio in Q3 2026.
- Bonness Enterprises opened 2 new positions and closed 0 in Q3 2026.
- Bonness Enterprises's portfolio value fell 0.84% quarter-over-quarter to $307M.
Based on Bonness Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.